Irit Huber

Haifa, HA, Israel

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Recellularized Humanized Bioengineered Biatrial Model for Arrhythmia, Biological Pacemakers, and Optogenetic Studies.

Recellularized Humanized Bioengineered Biatrial Model for Arrhythmia, Biological Pacemakers, and Optogenetic Studies.

Journal: Circulation research

Published: March 23, 2026

XPRESSO: Rapid genetic engineering of human pluripotent stem cells for durable overexpression using a modular anti-silencing vector.

XPRESSO: Rapid genetic engineering of human pluripotent stem cells for durable overexpression using a modular anti-silencing vector.

Journal: Stem cell reports

Published: June 14, 2024

Utilizing Human-Induced Pluripotent Stem Cells to Study Cardiac Electroporation Pulsed-Field Ablation.

Utilizing Human-Induced Pluripotent Stem Cells to Study Cardiac Electroporation Pulsed-Field Ablation.

Journal: Circulation. Arrhythmia and electrophysiology

Published: February 12, 2024

Chemogenetics for Gene Therapy Based Targeted Cardiac Electrophysiological Modulation.

Chemogenetics for Gene Therapy Based Targeted Cardiac Electrophysiological Modulation.

Journal: Circulation research

Published: February 06, 2023

Utilizing human induced pluripotent stem cells to study atrial arrhythmias in the short QT syndrome.

Utilizing human induced pluripotent stem cells to study atrial arrhythmias in the short QT syndrome.

Journal: Journal of molecular and cellular cardiology

Published: August 24, 2022

shRNAs Targeting a Common KCNQ1 Variant Could Alleviate Long-QT1 Disease Severity by Inhibiting a Mutant Allele.

shRNAs Targeting a Common KCNQ1 Variant Could Alleviate Long-QT1 Disease Severity by Inhibiting a Mutant Allele.

Journal: International journal of molecular sciences

Published: February 28, 2022

Optogenetic Control of Human Induced Pluripotent Stem Cell-Derived Cardiac Tissue Models.

Optogenetic Control of Human Induced Pluripotent Stem Cell-Derived Cardiac Tissue Models.

Journal: Journal of the American Heart Association

Published: February 03, 2022

Characterization of the mechanism by which a nonsense variant in RYR2 leads to disordered calcium handling.

Characterization of the mechanism by which a nonsense variant in RYR2 leads to disordered calcium handling.

Journal: Physiological reports

Published: January 20, 2022

Using Decellularization/Recellularization Processes to Prepare Liver and Cardiac Engineered Tissues.

Using Decellularization/Recellularization Processes to Prepare Liver and Cardiac Engineered Tissues.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: February 19, 2021

Optogenetic modulation of cardiac action potential properties may prevent arrhythmogenesis in short and long QT syndromes.

Optogenetic modulation of cardiac action potential properties may prevent arrhythmogenesis in short and long QT syndromes.

Journal: JCI insight

Published: January 07, 2021

Modeling Peripartum Cardiomyopathy With Human Induced Pluripotent Stem Cells Reveals Distinctive Abnormal Function of Cardiomyocytes.

Modeling Peripartum Cardiomyopathy With Human Induced Pluripotent Stem Cells Reveals Distinctive Abnormal Function of Cardiomyocytes.

Journal: Circulation

Published: December 21, 2018

Engineered heart tissue models from hiPSC-derived cardiomyocytes and cardiac ECM for disease modeling and drug testing applications.

Engineered heart tissue models from hiPSC-derived cardiomyocytes and cardiac ECM for disease modeling and drug testing applications.

Journal: Acta biomaterialia

Published: October 09, 2018

Showing 1-12 of 19

Last Updated: 09/26/2026